Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity.

× No keyword cloud information.

20 in total

1. Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors: Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal: N Engl J Med Date: 2006-11-16 Impact factor: 91.245

2. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.

Authors: Akio Hirata; Tetsuo Minamino; Hiroshi Asanuma; Masashi Fujita; Masakatsu Wakeno; Masafumi Myoishi; Osamu Tsukamoto; Ken-ichiro Okada; Hidekazu Koyama; Kazuo Komamura; Seiji Takashima; Yoshiro Shinozaki; Hidezo Mori; Masamichi Shiraga; Masafumi Kitakaze; Masatsugu Hori
Journal: J Am Coll Cardiol Date: 2006-06-21 Impact factor: 24.094

Review 3. STAT3-mediated activation of myocardial capillary growth.

Authors: Denise Hilfiker-Kleiner; Anne Limbourg; Helmut Drexler
Journal: Trends Cardiovasc Med Date: 2005-05 Impact factor: 6.677

4. Correction of anemia with epoetin alfa in chronic kidney disease.

Authors: Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal: N Engl J Med Date: 2006-11-16 Impact factor: 91.245

5. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.

Authors: Longhu Li; Genzou Takemura; Yiwen Li; Shusaku Miyata; Masayasu Esaki; Hideshi Okada; Hiromitsu Kanamori; Ngin Cin Khai; Rumi Maruyama; Atsushi Ogino; Shinya Minatoguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal: Circulation Date: 2006-01-31 Impact factor: 29.690

6. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice.

Authors: Makoto Nakano; Kimio Satoh; Yoshihiro Fukumoto; Yoshitaka Ito; Yutaka Kagaya; Naoto Ishii; Kazuo Sugamura; Hiroaki Shimokawa
Journal: Circ Res Date: 2007-02-09 Impact factor: 17.367

7. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.

Authors: Peter van der Meer; Erik Lipsic; Robert H Henning; Rudolf A de Boer; Albert J H Suurmeijer; Dirk J van Veldhuisen; Wiek H van Gilst
Journal: Eur J Heart Fail Date: 2004-12 Impact factor: 15.534

8. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

Authors: B Daan Westenbrink; Erik Lipsic; Peter van der Meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Journal: Eur Heart J Date: 2007-06-17 Impact factor: 29.983

Review 9. Microvascular involvement in cardiac pathology.

Authors: J B Gavin; L Maxwell; S G Edgar
Journal: J Mol Cell Cardiol Date: 1998-12 Impact factor: 5.000

10. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors: Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal: J Clin Invest Date: 2005-08 Impact factor: 14.808